Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Avian Influenza
New vaccine seeks to tame bird flu
September 8th, 2004
The National Institutes of Health awarded Chiron Corp. a $1.194 million contract to develop up to 40,000 doses of vaccine against H9N2 avian influenza, a type of bird flu that is less lethal but more widespread than the strain that killed 27 this year in Asia. The August issue of the Journal of Virology suggested the H9N2 strain has gotten hotter in recent years, killing far more lab mice than the same strain that circulated just 4 years earlier. That increased virulence, its prevalence among birds and the ability of the H9N2 virus to infect humans raises fears it could trigger a pandemic, scientists warned. Already, the H9N2 bird flu showed...
Source: Vaccine Weekly (2004-09-08)
|
